Proteasome and Heat Shock Protein 70 (HSP70) Inhibitors as Therapeutic Alternative in Multiple Myeloma

Oncotarget - United States
doi 10.18632/oncotarget.22815
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

MAFb Protein Confers Intrinsic Resistance to Proteasome Inhibitors in Multiple Myeloma

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Inhibition of Heat Shock Protein 70 and 90 (Hsp70 and Hsp90) in Target Spesific Cancer Treatment

Advanced Techniques in Biology & Medicine
2015English

Immunohistochemistry of Heat Shock Protein 70 (Hsp70) on Earthworm (Lumbricus Terrestris) in Gold Mining Sites

Journal of Applied Biotechnology
2014English

Phylogenetic Relationships of Cryptosporidium Parasites Based on the 70-Kilodalton Heat Shock Protein (HSP70) Gene

Applied and Environmental Microbiology
Applied MicrobiologyBiotechnologyEcologyFood Science
2000English

Proteasome Inhibitors Block Ikaros Degradation by Lenalidomide in Multiple Myeloma

Haematologica
Hematology
2015English

Heat Shock Protein 70 Inhibitors Suppress Androgen Receptor Expression in LNCaP95 Prostate Cancer Cells

Cancer Science
Cancer ResearchMedicineOncology
2017English

Cofilin-Actin Rod Formation in Experimental Stroke Is Attenuated by Therapeutic Hypothermia and Overexpression of the Inducible 70 kD Inducible Heat Shock Protein (Hsp70)

Brain Circulation
2019English

Proteasome Inhibitors Block Myeloma-Induced Osteocyte Death in Vitro and in Vivo in Multiple Myeloma Patients

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Release of Heat Shock Protein 70 (Hsp70) and the Effects of Extracellular Hsp70 on Matric Metalloproteinase-9 Expression in Human Monocytic U937 Cells

Experimental & Molecular Medicine
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy